Literature DB >> 16533039

One functional switch mediates reversible and irreversible inactivation of a herpesvirus protease.

Anson M Nomura1, Alan B Marnett, Nobuhisa Shimba, Volker Dötsch, Charles S Craik.   

Abstract

Distinct mechanisms have evolved to regulate the function of proteolytic enzymes. Viral proteases in particular have developed novel regulatory mechanisms, presumably due to their comparatively rapid life cycles and responses to constant evolutionary pressure. Herpesviruses are a family of human pathogens that require a viral protease with a concentration-dependent zymogen activation involving folding of two alpha-helices and activation of the catalytic machinery, which results in formation of infectious virions. Kaposi's sarcoma-associated herpesvirus protease (KSHV Pr) is unique among the herpesvirus proteases in possessing an autolysis site in the dimer interface, which removes the carboxyl-terminal 27 amino acids comprising an alpha-helix adjacent to the active site. Truncation results in the irreversible loss of dimerization and concomitant inactivation. We characterized the conformational and functional differences between the active dimer, inactive monomer, and inactive truncated protease to determine the different protease regulatory mechanisms that control the KSHV lytic cycle. Circular dichroism revealed a loss of 31% alpha-helicity upon dimer dissociation. Comparison of the full-length and truncated monomers by NMR showed differences in 21% of the protein structure, mainly located adjacent to the dimer interface, with little perturbation of the overall protein upon truncation. Fluorescence polarization and active site labeling, with a transition state mimetic, characterized the functional effects of these conformational changes. Substrate turnover is abolished in both the full-length and truncated monomers; however, substrate binding remained intact. Disruption of the helix 6 interaction with the active site oxyanion loop is therefore used in two independent regulatory mechanisms of proteolytic activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533039     DOI: 10.1021/bi0523658

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

Review 1.  Allosteric regulation of protease activity by small molecules.

Authors:  Aimee Shen
Journal:  Mol Biosyst       Date:  2010-06-10

2.  Substrate modulation of enzyme activity in the herpesvirus protease family.

Authors:  Ana Lazic; David H Goetz; Anson M Nomura; Alan B Marnett; Charles S Craik
Journal:  J Mol Biol       Date:  2007-08-16       Impact factor: 5.469

3.  Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.

Authors:  Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 4.  Using specificity to strategically target proteases.

Authors:  Mark D Lim; Charles S Craik
Journal:  Bioorg Med Chem       Date:  2008-03-30       Impact factor: 3.641

5.  Enzyme inhibition by allosteric capture of an inactive conformation.

Authors:  Gregory M Lee; Tina Shahian; Aida Baharuddin; Jonathan E Gable; Charles S Craik
Journal:  J Mol Biol       Date:  2011-06-22       Impact factor: 5.469

6.  Inhibition of a viral enzyme by a small-molecule dimer disruptor.

Authors:  Tina Shahian; Gregory M Lee; Ana Lazic; Leggy A Arnold; Priya Velusamy; Christina M Roels; R Kiplin Guy; Charles S Craik
Journal:  Nat Chem Biol       Date:  2009-07-26       Impact factor: 15.040

7.  A screening strategy for trapping the inactive conformer of a dimeric enzyme with a small molecule inhibitor.

Authors:  Charles S Craik; Tina Shahian
Journal:  Methods Mol Biol       Date:  2012

8.  Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric Protease.

Authors:  Jonathan E Gable; Gregory M Lee; Timothy M Acker; Kaitlin R Hulce; Eric R Gonzalez; Patrick Schweigler; Samu Melkko; Christopher J Farady; Charles S Craik
Journal:  ChemMedChem       Date:  2016-01-28       Impact factor: 3.466

9.  Broad-spectrum allosteric inhibition of herpesvirus proteases.

Authors:  Jonathan E Gable; Gregory M Lee; Priyadarshini Jaishankar; Brian R Hearn; Christopher A Waddling; Adam R Renslo; Charles S Craik
Journal:  Biochemistry       Date:  2014-07-11       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.